Hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased systemic vascular resistance due to endothelial dysfunction and heightened sympathetic nervous system activity, leading to sustained vasoconstriction and elevated blood pressure.

• Secondary mechanism: Dysregulation of the renin-angiotensin-aldosterone system (RAAS), causing excessive angiotensin II production, which promotes vasoconstriction and stimulates aldosterone release, resulting in sodium and water retention.

• Key complication: Persistent hypertension can lead to severe complications such as left ventricular hypertrophy, due to increased afterload, and progressive renal damage, driven by glomerular hyperfiltration and sclerosis.

Patient Profile

Demographics:

68, male, retired construction worker

History:

• Key past medical history: Chronic kidney disease, Type 2 diabetes mellitus, hyperlipidemia, previous myocardial infarction

• Current medications: Lisinopril, Metoprolol, Amlodipine, Simvastatin, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and shortness of breath

• Key symptoms: Dizziness, blurred vision, chest pain, swelling in legs

• Vital signs: Blood pressure 210/120 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 88% on room air

Section 1

Initial Assessment Findings:

Upon initial assessment, the patient's condition presented with several alarming findings that demanded prompt intervention. The patient exhibited acute respiratory distress, evidenced by labored breathing and the use of accessory muscles, coupled with an oxygen saturation that had further decreased to 85% despite supplemental oxygen via nasal cannula. Auscultation of the lungs revealed bilateral crackles, suggesting pulmonary congestion or edema likely secondary to acute decompensated heart failure. Cardiac examination revealed a gallop rhythm with an S4 heart sound, indicative of left ventricular hypertrophy and decreased compliance. Peripheral edema was noted to be 3+ pitting, extending up to the mid-thigh, consistent with fluid overload.

Lab results were significant for elevated serum creatinine, now at 2.5 mg/dL from a baseline of 1.8 mg/dL, indicating acute kidney injury on chronic kidney disease. B-type natriuretic peptide (BNP) levels were markedly elevated at 1,200 pg/mL, confirming volume overload and cardiac strain. Electrolyte imbalances were noted, with a potassium level of 5.8 mmol/L, raising concerns for potential arrhythmias. An ECG showed sinus tachycardia with nonspecific ST-T wave changes, and left ventricular hypertrophy with strain pattern. These findings underscore the critical nature of the patient's hypertension-related complications, necessitating immediate, multifaceted management to prevent further deterioration.

In response to these findings, the healthcare team prioritized aggressive blood pressure control and diuresis to alleviate the patient's symptoms and prevent further end-organ damage. This involved initiating an intravenous nitroglycerin infusion to achieve rapid vasodilation and a loop diuretic to manage fluid overload. Continuous monitoring in an intensive care setting was deemed necessary to closely observe the patient's response to treatment and adjust the therapeutic approach accordingly. The complex interplay of the patient's comorbid conditions, such as chronic kidney disease and heart failure, required advanced critical thinking to balance the treatment of hypertension without further compromising renal function.

Section 2

As the patient remained in the intensive care unit under close observation, the healthcare team noted a change in the patient's status approximately six hours after the initiation of treatment. Despite the administration of intravenous nitroglycerin and loop diuretics, the patient's blood pressure remained elevated at 180/110 mmHg. The persistent hypertension suggested a refractory component, possibly due to secondary causes that had not been addressed. Furthermore, the patient began exhibiting signs of decreasing mental status, with increased confusion and disorientation, raising concerns for hypertensive encephalopathy or an acute cerebrovascular event.

Additional diagnostic imaging, including a CT scan of the head, was promptly conducted to rule out intracranial hemorrhage. While the scan did not show any acute bleeding, it revealed signs of chronic small vessel ischemic changes, likely exacerbated by the uncontrolled hypertension. Concurrently, repeat laboratory tests showed a further elevation in serum creatinine to 3.0 mg/dL, indicating worsening renal function despite attempts to manage the fluid overload. Electrolyte levels remained concerning, with potassium increasing to 6.2 mmol/L, necessitating urgent measures to prevent life-threatening arrhythmias.

In response to these developments, the medical team convened to reassess the treatment plan. Considering the evolving condition, they decided to introduce additional antihypertensive agents with different mechanisms of action, such as a calcium channel blocker and an alpha-beta blocker, to achieve better blood pressure control. Furthermore, measures to address the hyperkalemia were immediately implemented, including the administration of calcium gluconate, insulin with dextrose, and a potassium binder to reduce the risk of cardiac complications. The complexity of the patient's condition required meticulous coordination among the cardiology, nephrology, and neurology teams to ensure a comprehensive approach to management, highlighting the critical importance of advanced clinical judgment in navigating this challenging case.

Section 3

Following the implementation of the revised treatment plan, the patient initially showed signs of stabilization; however, within the next few hours, new complications emerged, prompting further evaluation by the healthcare team. Despite the aggressive management of hyperkalemia, the patient experienced a sudden episode of ventricular tachycardia, which required immediate intervention with intravenous antiarrhythmic medications and continuous cardiac monitoring. This acute cardiac event underscored the precarious balance of the patient's electrolyte levels and the ongoing challenges in achieving hemodynamic stability.

Concurrently, the patient's neurological status continued to decline, with increasing lethargy and intermittent episodes of agitation. A repeat CT scan of the head was conducted, revealing no new structural abnormalities, but an electroencephalogram (EEG) was ordered to assess for possible seizure activity, given the altered mental status. The EEG results indicated diffuse slowing, suggestive of metabolic encephalopathy rather than focal seizure activity, aligning with the ongoing hypertensive crisis and renal impairment.

In light of these developments, the medical team expanded their diagnostic scope to investigate potential secondary causes of the refractory hypertension, such as pheochromocytoma or renovascular disease. Additional tests, including plasma metanephrines and renal artery Doppler studies, were initiated. Meanwhile, adjustments to the medication regimen were made to optimize both renal perfusion and blood pressure control, incorporating an angiotensin receptor blocker cautiously due to the renal function concerns. This multifaceted approach required continuous reassessment and precise coordination across the multidisciplinary team, highlighting the complexity of managing a patient with severe hypertensive complications and emphasizing the need for vigilant monitoring and dynamic clinical judgment.

Section 4

New Diagnostic Results:

As the healthcare team awaited the results from the plasma metanephrines and renal artery Doppler studies, additional laboratory data revealed further complexities in the patient's condition. The patient's serum creatinine had risen to 3.2 mg/dL from the previous 2.8 mg/dL, indicating a worsening renal function despite efforts to maintain renal perfusion. The arterial blood gas analysis showed a pH of 7.32, PaCO2 of 36 mmHg, and HCO3- of 18 mEq/L, suggesting a metabolic acidosis that compounded the metabolic encephalopathy observed on EEG. Concurrently, the patient's potassium levels, which had been aggressively managed, dropped to 3.1 mEq/L, raising concerns of hypokalemia and the risk of further cardiac arrhythmias.

The results of the renal artery Doppler studies were particularly telling, revealing significant stenosis in the left renal artery, consistent with renovascular hypertension. This finding provided a potential explanation for the refractory nature of the patient's hypertension and renal impairment. However, the plasma metanephrines returned within normal limits, effectively ruling out pheochromocytoma as a secondary cause, narrowing the team's diagnostic focus.

In light of these findings, the healthcare team faced critical decisions on the next steps for intervention. The confirmation of renal artery stenosis suggested a need for possible revascularization procedures, yet the patient's current unstable status posed significant risks for invasive interventions. This necessitated a careful weighing of risks and benefits, as well as a consideration of alternative, less invasive approaches to improve renal blood flow and control blood pressure. The complexity of these decisions underscored the importance of interdisciplinary collaboration and the application of advanced clinical reasoning skills to navigate the patient's challenging clinical course.

Section 5

The healthcare team decided to initiate a cautious approach to manage the patient's condition, prioritizing stabilization with medical therapy while evaluating the potential for revascularization. The interdisciplinary team, including nephrologists, cardiologists, and interventional radiologists, focused on optimizing antihypertensive therapy with medications that could also improve renal perfusion. Angiotensin-converting enzyme (ACE) inhibitors were considered, but given the elevated serum creatinine, their use was debated due to the risk of further renal compromise. Instead, a calcium channel blocker was introduced to better manage the blood pressure and potentially enhance renal blood flow without exacerbating the renal impairment.

Despite these efforts, the patient's clinical status changed dramatically over the next 24 hours. The patient developed worsening neurological symptoms, with increasing confusion and disorientation, suggesting a possible hypertensive crisis or worsening metabolic encephalopathy. Vital signs revealed a blood pressure of 198/110 mmHg, heart rate of 112 bpm, and respiratory rate of 24 breaths per minute. The laboratory results showed a further decline in bicarbonate levels to 16 mEq/L and a drop in potassium to 2.8 mEq/L, intensifying the metabolic acidosis and hypokalemia.

Given these developments, the team needed to act swiftly to prevent further deterioration. The risk of cardiac arrhythmias due to the severe hypokalemia required immediate attention, prompting the initiation of intravenous potassium supplementation. Simultaneously, the team reassessed the patient's eligibility for urgent renal artery angioplasty, considering the acute exacerbation of symptoms and the potential for rapidly improving renal function and stabilizing blood pressure if revascularization was successful. However, the risk of contrast-induced nephropathy loomed, necessitating a delicate balance between aggressive intervention and conservative management to guide the next steps in the patient's care.